BR112022004569A2 - Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais - Google Patents

Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais

Info

Publication number
BR112022004569A2
BR112022004569A2 BR112022004569A BR112022004569A BR112022004569A2 BR 112022004569 A2 BR112022004569 A2 BR 112022004569A2 BR 112022004569 A BR112022004569 A BR 112022004569A BR 112022004569 A BR112022004569 A BR 112022004569A BR 112022004569 A2 BR112022004569 A2 BR 112022004569A2
Authority
BR
Brazil
Prior art keywords
dsm
bacterial strains
compositions
treatment
gastrointestinal disorders
Prior art date
Application number
BR112022004569A
Other languages
English (en)
Inventor
Andrea Biffi
Walter Fiore
Original Assignee
Sofar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar Spa filed Critical Sofar Spa
Publication of BR112022004569A2 publication Critical patent/BR112022004569A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais. a presente invenção refere-se a estirpes bacterianas, tais como: b. breve bbibs01 (dsm 33231), b. breve bbibs02 (dsm 33232), b. animalis subsp. lactis blibs01 (dsm 33233) e l. plantarum lpibs01 (dsm 33234). além disso, a presente invenção refere-se a composições compreendendo uma mistura compreendendo ou, alternativamente, consistindo em pelo menos uma ou mais das cepas bacterianas acima mencionadas e, opcionalmente, pelo menos uma cepa bacteriana adicional, selecionada de uma cepa bacteriana l. casei dg® (cncm i-1572) e cepa bacteriana l. paracasei lpc-s01 (dsm 26760). por último, a presente invenção refere-se às referidas cepas bacterianas ou misturas das mesmas para uso em um método para o tratamento de doenças, distúrbios ou sintomas gastrointestinais, em particular distúrbios gastrointestinais funcionais, como, por exemplo, síndrome do intestino irritável (sii).
BR112022004569A 2019-09-20 2020-09-21 Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais BR112022004569A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000016805A IT201900016805A1 (it) 2019-09-20 2019-09-20 Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
PCT/IB2020/058774 WO2021053639A1 (en) 2019-09-20 2020-09-21 Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
BR112022004569A2 true BR112022004569A2 (pt) 2022-06-07

Family

ID=69375782

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004569A BR112022004569A2 (pt) 2019-09-20 2020-09-21 Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais

Country Status (11)

Country Link
US (1) US20220325234A1 (pt)
EP (1) EP4031650A1 (pt)
JP (1) JP2023507705A (pt)
CN (1) CN114727640A (pt)
AU (1) AU2020351354A1 (pt)
BR (1) BR112022004569A2 (pt)
CA (1) CA3154979A1 (pt)
IL (1) IL291460A (pt)
IT (1) IT201900016805A1 (pt)
MX (1) MX2022003374A (pt)
WO (1) WO2021053639A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN110893194B (zh) * 2019-11-20 2023-03-14 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99在抑制肠道炎症方面的新应用
IT202100008300A1 (it) * 2021-04-01 2022-10-01 Bll Invest S R L Ceppi di batteri inattivati, quali batteri vitali ma non coltivabili, loro composizioni e loro uso
IT202100017855A1 (it) * 2021-07-06 2023-01-06 Lac2Biome S R L Bacteria strains for topical skin care
CN114350577B (zh) * 2022-03-17 2022-05-27 微康益生菌(苏州)股份有限公司 一种改善便秘的动物双歧杆菌乳亚种BLa36及其培养方法与应用
IT202200010244A1 (it) * 2022-05-17 2023-11-17 Alfasigma Spa Lacticaseibacillus paracasei DG® CNCM I-1572 DSM 34154 per uso in un metodo di trattamento della disbiosi in pazienti affetti da IBS
WO2024089260A1 (en) * 2022-10-28 2024-05-02 Chr. Hansen A/S Lactiplantibacillus plantarum for use in addressing the symptoms of irritable bowel syndrome
CN116948918B (zh) * 2023-09-18 2023-12-19 微康益生菌(苏州)股份有限公司 一种抗幽门螺杆菌感染的短双歧杆菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100166721A1 (en) * 2006-06-09 2010-07-01 Fabiola Masri Probotic compositions and uses thereof
RU2011139211A (ru) * 2009-03-05 2013-04-10 Пробиотикал С.п.А. Бактериальные штаммы, обладающие высокой противовоспалительной активностью
WO2019019961A1 (zh) * 2017-07-26 2019-01-31 海思科医药集团股份有限公司 防治消化道和/或皮肤反应的菌群及其应用

Also Published As

Publication number Publication date
JP2023507705A (ja) 2023-02-27
IT201900016805A1 (it) 2021-03-20
CA3154979A1 (en) 2021-03-25
WO2021053639A1 (en) 2021-03-25
IL291460A (en) 2022-05-01
EP4031650A1 (en) 2022-07-27
CN114727640A (zh) 2022-07-08
US20220325234A1 (en) 2022-10-13
MX2022003374A (es) 2022-04-12
AU2020351354A1 (en) 2022-03-31

Similar Documents

Publication Publication Date Title
BR112022004569A2 (pt) Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais
BR112022004432A2 (pt) Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais
BR112022004527A2 (pt) Composições com base em cepas bacterianas e seu uso como anti-inflamatórios
BR112022004976A2 (pt) Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios
NZ777234A (en) Compositions comprising bacterial strains
Chen et al. Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells
Mohanty et al. In vitro evaluation of adherence and anti-infective property of probiotic Lactobacillus plantarum DM 69 against Salmonella enterica
Garriga et al. Potentially probiotic and bioprotective lactic acid bacteria starter cultures antagonise the Listeria monocytogenes adhesion to HT29 colonocyte-like cells
MX2008006546A (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
Liu et al. Gut microbiota alterations from different Lactobacillus probiotic-fermented yoghurt treatments in slow-transit constipation
US20120128633A1 (en) Use of collinsella aerofaciens for reducing bloating
BR112018003123A2 (pt) composição, enema, cepa isolada, método para tratamento e/ou prevenção de uma condição gastrointestinal, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada
MX2022002949A (es) Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
Rather et al. Antiviral mode of action of Lactobacillus plantarum YML009 on Influenza virus H1N1
MA44893A1 (fr) Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique
MX2022000369A (es) Cepa bacteriana de bifidobacterium bifidum, las composiciones de la misma y usos relacionados.
MX2021009398A (es) Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso.
MX2020013439A (es) Composiciones probioticas y usos de las mismas.
BR112022024128A2 (pt) Composição de microbiota vaginal, e, método para tratar uma infecção
RU2017138021A (ru) Композиция для сокращения выработки кишечного газа
Tanriover et al. Use of probiotics in various diseases: Evidence and promises
Park et al. Effect of Lactobacillus plantarum FH185 on the reduction of adipocyte size and gut microbial changes in mice with diet-induced obesity
Rocchetti et al. Immunomodulatory activity on human macrophages by cell-free supernatants to explore the probiotic and postbiotic potential of Lactiplantibacillus plantarum strains of plant origin
MX2022008666A (es) Composicion probiotica para su uso como antioxidante.
Bunesova et al. Isolation and characterization of bifidobacteria from ovine cheese

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]